Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+22.2%/yr
vs -12.1%/yr prior
Acceleration
+34.3pp
Accelerating
Percentile
P82
Within normal range
vs 3Y Ago
1.8x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 21.88% |
| Q3 2025 | -260.00% |
| Q2 2025 | -94.33% |
| Q1 2025 | 396.64% |
| Q4 2024 | 59.39% |
| Q3 2024 | 5.48% |
| Q2 2024 | 45.10% |
| Q1 2024 | 59.61% |
| Q4 2023 | 14.76% |
| Q3 2023 | 3.02% |
| Q2 2023 | 5.95% |
| Q1 2023 | 0.50% |
| Q4 2022 | 11.98% |
| Q3 2022 | -552.20% |
| Q2 2022 | 120.76% |
| Q1 2022 | 8.72% |
| Q4 2021 | -5.97% |
| Q3 2021 | 0.53% |
| Q2 2021 | -6.17% |
| Q1 2021 | 10.16% |
| Q4 2020 | -4.06% |
| Q3 2020 | 19.62% |
| Q2 2020 | 5.10% |
| Q1 2020 | 11.78% |
| Q4 2019 | -3.97% |
| Q3 2019 | 18.22% |
| Q2 2019 | -11.45% |
| Q1 2019 | 17.83% |
| Q4 2018 | -36.01% |
| Q3 2018 | -12.11% |
| Q2 2018 | -9.51% |
| Q1 2018 | 9.13% |
| Q4 2017 | -12.90% |
| Q3 2017 | -8.78% |
| Q2 2017 | -6.25% |
| Q1 2017 | -39.95% |
| Q4 2016 | 28.38% |
| Q3 2016 | -33.70% |
| Q2 2016 | -13.51% |
| Q1 2016 | 22.41% |